Tea and cancer prevention: Studies in animals and humans

被引:206
作者
Chung, FL [1 ]
Schwartz, J [1 ]
Herzog, CR [1 ]
Yang, YM [1 ]
机构
[1] Amer Hlth Fdn, Ctr Canc, Inst Canc Prevent, Valhalla, NY 10595 USA
关键词
green tea; black tea; lung cancer; oral cancer; smokers; antioxidant;
D O I
10.1093/jn/133.10.3268S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The role of tea in protection against cancer has been supported by ample evidence from studies in cell culture and animal models. However, epidemiological studies have generated inconsistent results, some of which associated tea with reduced risk of cancer, whereas others found that tea lacks protective activity against certain human cancers. These results raise questions about the actual role of tea in human cancer that needs to be addressed. This article is intended to provide a better perspective on this controversy by summarizing the laboratory studies in animals and humans with emphasis on animal tumor bioassays on skin, lung, mammary glands and colon, and the molecular and cellular mechanisms affected by tea. Finally, a recent small pilot intervention study with green tea in smokers is presented.
引用
收藏
页码:3268S / 3274S
页数:7
相关论文
共 29 条
[1]   Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate [J].
Ahmad, N ;
Cheng, PY ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :328-334
[2]   Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells [J].
Ahmad, N ;
Feyes, DK ;
Nieminen, AL ;
Agarwal, R ;
Mukhtar, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) :1881-1886
[3]  
August DA, 1999, CANCER EPIDEM BIOMAR, V8, P709
[4]   EVALUATION OF DNA DAMAGE IN THE ORAL-MUCOSA OF TOBACCO USERS AND NON-USERS BY P-32-ADDUCT ASSAY [J].
CHACKO, M ;
GUPTA, RC .
CARCINOGENESIS, 1988, 9 (12) :2309-2313
[5]  
Chen WX, 1999, MOL CARCINOGEN, V24, P79, DOI 10.1002/(SICI)1098-2744(199902)24:2<79::AID-MC1>3.0.CO
[6]  
2-E
[7]  
Chung FL, 1998, CANCER RES, V58, P4096
[8]  
Chung JY, 1999, CANCER RES, V59, P4610
[9]   A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs [J].
Eichhorst, ST ;
Müller, M ;
Li-Weber, M ;
Schulze-Bergkamen, H ;
Angel, P ;
Krammer, PH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7826-7837
[10]   Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [J].
Graeber, TG ;
Osmanian, C ;
Jacks, T ;
Housman, DE ;
Koch, CJ ;
Lowe, SW ;
Giaccia, AJ .
NATURE, 1996, 379 (6560) :88-91